Current oncology reports

publication venue for

Is maintenance rituximab now ready for PRIMA-time?. 12. 2010
Do six or eight cycles work better with CHOP-14 and rituximab?. 10. 2008
New strategies in radioimmunotherapy for lymphoma.. 5. 2003
Meta-analysis: making sense of maintenance rituximab? 2009
Two regimens of docetaxel for metastatic breast cancer. 2005
Cancer Pain Management-New Therapies. 2022
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients. 2021
Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia. 2021
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer. 2021
Medulloblastoma: an Old Diagnosis with New Promises. 2020
Management of the Small Renal Mass: a 2020 Update. 2020
Antibody-Drug Conjugates in Urothelial Carcinomas. 2020
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets. 2019
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers. 2018
Molecular Subtypes of Prostate Cancer. 2018
Checkpoint Inhibitors in the Treatment of Breast Cancer. 2018
The Impact of Obesity on Breast Cancer. 2018
Updates on Primary Central Nervous System Lymphoma. 2018
Emerging Variants of Castration-Resistant Prostate Cancer. 2017
Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy. 2017
Prophylactic Measures During Induction for Acute Myeloid Leukemia. 2017
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition. 2016
Communication About Sexuality in Advanced Illness Aligns With a Palliative Care Approach to Patient-Centered Care. 2016
High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma. 2015
Novel agents in mantle cell lymphoma. 2015
Radical surgery in ovarian cancer. 2015
Defining value-driven care in head and neck oncology. 2015
Optimal treatment for metastatic bladder cancer. 2014
Advances in the management of central nervous system germ cell tumors. 2014
Checkpoint modulation in melanoma: an update on ipilimumab and future directions. 2013
Genetic factors and pathogenesis of Waldenström's macroglobulinemia. 2013
Dermatological adverse events from BRAF inhibitors: a growing problem. 2013
Active immunotherapy: current state of the art in vaccine approaches for NHL. 2012
Mucosal melanoma: pathogenesis, clinical behavior, and management. 2012
Novel agents in Hodgkin lymphoma. 2012
Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different? 2012
The "SWOT" of BRAF inhibition in melanoma: RAF inhibitors, MEK inhibitors or both? 2011
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury? 2011
Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. 2010
Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting? 2010
Evolving treatment of advanced colorectal cancer. 2010
Exercise therapy across the lung cancer continuum. 2009
The impact of new data in the treatment of advanced hepatocellular carcinoma. 2008
Current treatment and management of retinoblastoma. 2007
Innovative laparoscopic surgery in gynecologic oncology. 2007
Operative management of primary epithelial ovarian cancer. 2007
Diagnosis and treatment of acute promyelocytic leukemia. 2007
Unusual histologic and clinical variants of melanoma: implications for therapy. 2007
Update on HIV lymphoma. 2007
Taxanes in breast cancer: an update. 2007
Novel approaches in allogeneic stem cell transplantation. 2006
Gastric cancer: an update. 2006
Update on hereditary breast cancer. 2006
The merits of vascular targeting for gynecologic malignancies. 2005
What are SNPs and haplotypes and how will they help us manage the prevention of adult cancer? 2005
Advances in the molecular genetics of acute leukemia. 2005
New developments in immunotherapy for non-Hodgkin's lymphoma. 2005
Functional imaging in head and neck cancer. 2005
Adjuvant chemotherapy for primary breast cancer. 2005
Diagnosis and treatment of primary central nervous system lymphoma. 2005
Novel approaches to immunotherapy for B-cell malignancies. 2004
Primary central nervous system lymphoma. 2004
The genetics of familial lymphomas. 2004
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer. 2004
Management of patients with locally advanced breast cancer. 2004
The evolving role of partial nephrectomy in the management of renal cell carcinoma. 2003
Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease. 2002
New developments in the treatment of esophageal cancer. 2002
Recent developments in the treatment of gastric carcinoma. 2002
An update on epidermal growth factor receptor inhibitors. 2002
Retinoid mechanisms and cyclins. 2001
STI571: a gene product-targeted therapy for leukemia. 2001
Monoclonal antibody-based therapy for neuroblastoma. 2000
Chemotherapy for androgen- independent prostate cancer: myth or reality. 2000
New treatment approaches for metastatic renal cell carcinoma. 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect. 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens. 2000
Old, new drugs and new, new drugs for the new millennium. 2000
The role of irinotecan in colorectal cancer. 1999

VIVO Weill Cornell Medical College

Current oncology reports Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)